This inventor holds 1 USPTO granted patent and 2 published patent applications and 5 EPO patents. Top assignee: Cardiac Pacemakers, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Manfred Franke: Innovator in Autonomic Modulation Therapy
Introduction
Manfred Franke is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical technology, particularly in autonomic modulation therapy. His innovative approach has the potential to enhance patient care through advanced neural stimulation techniques.
Latest Patents
Franke holds a patent for a method titled "Dosed delivery of autonomic modulation therapy." This patent describes a system that involves receiving a user programmable neural stimulation (NS) dose for intermittent neural stimulation (INS) therapy. The method includes delivering INS therapy to an autonomic neural target of a patient, which may involve delivering NS bursts and controlling the timing of these bursts based on sensed cardiac events. This innovative approach allows for a customizable treatment plan tailored to the patient's needs.
Career Highlights
Throughout his career, Manfred Franke has worked with prominent companies in the medical device industry. He has been associated with Cardiac Pacemakers, Inc. and Boston Scientific Scimed, Inc. His experience in these organizations has contributed to his expertise in developing advanced medical technologies.
Collaborations
Franke has collaborated with notable professionals in his field, including David J. Ternes and Jason J. Hamann. These collaborations have likely enriched his work and contributed to the development of innovative solutions in autonomic modulation therapy.
Conclusion
Manfred Franke's contributions to the field of autonomic modulation therapy exemplify the impact of innovation in medical technology. His patent and career achievements highlight his commitment to improving patient outcomes through advanced therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
